Francesc X. Ruiz
- Cell Biology top 2%
- Aldose Reductase and Taurine 19
- Virology top 5%
- HIV Research and Treatment 12
- Biochemistry top 5%
- Molecular Biology top 10%
- Heme Oxygenase-1 and Carbon Monoxide 9
- Retinoids in leukemia and cellular processes 4
- Infectious Diseases top 10%
- HIV/AIDS drug development and treatment 14
- SARS-CoV-2 and COVID-19 Research 4
-
- Prenatal Substance Exposure Effects 11
-
- Pneumocystis jirovecii pneumonia detection and treatment 4
- Co-authors
- Xavier ParésJaume FarrésA. PodjarnyA. Cousido-SiahA. MitschlerSergio PortéEddy ArnoldOriol Gallego
- Cited by
- Cell BiologyVirologyBiochemistry
- Journals
- Journal of Medicinal Chemistry (8 papers)Chemico-Biological Interactions (6 papers)Science Advances (3 papers)
- Partner nations
- United StatesSpainFrance
In The Last Decade
Francesc X. Ruiz
46 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 101
- Cell Biology 521
- Virology 129
- Biochemistry 123
- Molecular Biology 876
- Infectious Diseases 210
Countries citing papers authored by Francesc X. Ruiz
This map shows the geographic impact of Francesc X. Ruiz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesc X. Ruiz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesc X. Ruiz more than expected).
Fields of papers citing papers by Francesc X. Ruiz
This network shows the impact of papers produced by Francesc X. Ruiz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesc X. Ruiz. The network helps show where Francesc X. Ruiz may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Francesc X. Ruiz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | Design of a SARS-CoV-2 papain-like protease inhibitor with antiviral efficacy in a mouse modelbreakdown → | 2024 | 43 |
| 4 | 2023 | 4 | |
| 5 | 2023 | 16 | |
| 6 | 2022 | 18 | |
| 7 | 2021 | 14 | |
| 8 | 2021 | 6 | |
| 9 | 2021 | 40 | |
| 10 | 2020 | 9 | |
| 11 | 2020 | 37 | |
| 12 | 2020 | 42 | |
| 13 | 2015 | 23 | |
| 14 | 2014 | 30 | |
| 15 | 2014 | 22 | |
| 16 | 2013 | 22 | |
| 17 | 2012 | 76 | |
| 18 | 2012 | 32 | |
| 19 | 2011 | 26 | |
| 20 | 2008 | 68 |
About Francesc X. Ruiz
Francesc X. Ruiz is a scholar working on Virology, Cell Biology and Infectious Diseases, having authored 49 papers that have together received 1.7k indexed citations. Recurring topics across this work include Aldose Reductase and Taurine (19 papers), HIV/AIDS drug development and treatment (14 papers), HIV Research and Treatment (12 papers), Prenatal Substance Exposure Effects (11 papers), Heme Oxygenase-1 and Carbon Monoxide (9 papers), SARS-CoV-2 and COVID-19 Research (4 papers), Pneumocystis jirovecii pneumonia detection and treatment (4 papers) and Retinoids in leukemia and cellular processes (4 papers). The work is most often cited by research in Cell Biology (521 citations), Virology (129 citations) and Biochemistry (123 citations). Francesc X. Ruiz has collaborated with scholars based in United States, Spain and France. Frequent co-authors include Xavier Parés, Jaume Farrés, A. Podjarny, A. Cousido-Siah, A. Mitschler, Sergio Porté, Eddy Arnold, Oriol Gallego, Gilles Travé and Katia Zanier. Their work appears in journals such as Journal of Medicinal Chemistry, Chemico-Biological Interactions, Science Advances, Biochemical Journal and ACS Chemical Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.